Literature DB >> 10335941

Endometrial stromal sarcomas: immunohistochemical, electron microscopical and cytogenetic findings in two cases.

R Gil-Benso1, C López-Ginés, S Navarro, C Carda, A Llombart-Bosch.   

Abstract

Uterine sarcomas are approximately 3% of all malignant uterine corpus tumours. Of these, the tumours that originate solely in the stromal elements of the uterine wall are infrequent and have not been well characterized cytogenetically. We report two cases of endometrial stromal sarcomas (ESS), one low grade and one high grade, diagnosed by conventional histology, immunocytochemistry, electron microscopy and cytogenetics. Morphologically clear-cut differential structures were seen at optical, immunohistochemical, and electron microscopic levels, permitting a clear differential diagnosis. The low-grade ESS expressed hormonal receptors and vimentin, whereas the high-grade ESS showed no hormone receptors, high Ki-67 activity, and occasional cytokeratin-positive cells. Ultrastructurally, no malignant epithelial differentiation was seen in the tumour cells, but cilia were found in both cases. Cytogenetic study of the low-grade ESS showed pseudodiploid karyotype with chromosomes 6 and 20 rearranged. The high-grade ESS showed a complex karyotype with clonal numerical and structural anomalies. The chromosomes involved in the structural rearrangements were 1, 3, 6, 7, 13, 14, 15, 17, 19, and 21.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10335941     DOI: 10.1007/s004280050346

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  6 in total

1.  Metastatic low-grade endometrial stromal sarcoma of the sigmoid colon three years after hysterectomy.

Authors:  Yuki Asada; Hajime Isomoto; Fumitaka Akama; Noriko Nomura; Chun-Yang Wen; Haruhiko Nakao; Ikuo Murata; Kan Toriyama; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

Review 2.  Recent advances in the histological and molecular classification of endometrial stromal neoplasms.

Authors:  Joana Ferreira; Ana Félix; Jochen K Lennerz; Esther Oliva
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

3.  Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.

Authors:  Paolo Cotzia; Ryma Benayed; Kerry Mullaney; Esther Oliva; Ana Felix; Joana Ferreira; Robert A Soslow; Cristina R Antonescu; Marc Ladanyi; Sarah Chiang
Journal:  Am J Surg Pathol       Date:  2019-05       Impact factor: 6.394

4.  Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma.

Authors:  Ioannis Panagopoulos; Francesca Micci; Jim Thorsen; Ludmila Gorunova; Anne Mette Eibak; Bodil Bjerkehagen; Ben Davidson; Sverre Heim
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

5.  Endometrial stromal tumors: immunohistochemical and molecular analysis of potential targets of tyrosine kinase inhibitors.

Authors:  Carmen Balañá; Enrique de Álava; Ruth Sardinha; Teresa Hernández; Susana Fraile; Francesc Tresserra; August Vidal; Maria Carmén Gómez; Aurora Astudillo; Nieves Hernández; Javier Saenz de Santamaría; Jaume Ordi; Luis Gonçalves; Rafael Ramos
Journal:  Clin Sarcoma Res       Date:  2013-03-07

6.  Cytogenetic and molecular profile of endometrial stromal sarcoma.

Authors:  Francesca Micci; Ludmila Gorunova; Antonio Agostini; Lene E Johannessen; Marta Brunetti; Ben Davidson; Sverre Heim; Ioannis Panagopoulos
Journal:  Genes Chromosomes Cancer       Date:  2016-08-09       Impact factor: 5.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.